Humoral and cellular immunogenicity, effectiveness and safety of COVID-19 mRNA vaccination in patients with pediatric rheumatic diseases: A prospective cohort study.

Hamad Saied, Mohamad; van Straalen, Joeri W; de Roock, Sytze; Verduyn Lunel, Frans M; de Wit, Jelle; de Rond, Lia G H; Van Nieuwenhove, Erika; Vastert, Bas J; van Montfrans, Joris M; van Royen-Kerkhof, Annet; de Joode-Smink, Gerrie C J; Swart, Joost F; Wulffraat, Nico M; Jansen, Marc H A

Publication

Humoral and cellular immunogenicity, effectiveness and safety of COVID-19 mRNA vaccination in patients with pediatric rheumatic diseases: A prospective cohort study.

Hamad Saied, Mohamad; van Straalen, Joeri W; de Roock, Sytze; Verduyn Lunel, Frans M; de Wit, Jelle; de Rond, Lia G H; Van Nieuwenhove, Erika; Vastert, Bas J; van Montfrans, Joris M; van Royen-Kerkhof, Annet; de Joode-Smink, Gerrie C J; Swart, Joost F; Wulffraat, Nico M; Jansen, Marc H A

Type

Article

Language

en

Date

2024-01-22

Show all metadata

Title

Humoral and cellular immunogenicity, effectiveness and safety of COVID-19 mRNA vaccination in patients with pediatric rheumatic diseases: A prospective cohort study.

Published in

Vaccine 2024; 42(5):1145-1153

Humoral and cellular immunogenicity, effectiveness and safety of COVID-19 mRNA vaccination in patients with pediatric rheumatic diseases: A prospective cohort study.

Citations

Series / Report no.

Open Access

Type

Language

Date

Research Projects

Organizational Units

Journal Issue

Title

Translated Title

Published in

Abstract

Description

Publisher

Sponsors

DOI

PMID

URI

Additional Links

Embedded videos

Collections